Quick Answer
OS Therapies Inc reported Shares Outstanding of 37.11 million shares for fiscal year 2025.
OS Therapies Inc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 37.11M | +77.8% |
| 2024 | 20.87M | +290.8% |
| 2023 | 5.34M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 33.27M | +57.1% | +12.2% |
| June 30, 2025 | 29.66M | +395.2% | +39.0% |
| March 31, 2025 | 21.35M | +78.2% | +2.3% |
| December 31, 2024 | 20.87M | +290.8% | -1.5% |
| September 30, 2024 | 21.18M | — | +253.5% |
| June 30, 2024 | 5.99M | — | -50.0% |
| March 31, 2024 | 11.98M | — | +124.4% |
| December 31, 2023 | 5.34M | — | — |
- OS Therapies Inc showed an increase of +77.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2023–2025 period, OS Therapies Inc’s shares outstanding has grown by 595.0% (from 5.34 million shares to 37.11 million shares).
- The most recent figure is from OS Therapies Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: